| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology (D.D.L., M.J.P., L.K.H.), University of Cambridge, Cambridge CB2 1PD, United Kingdom; and Department of Clinical Biochemistry (D.D.L., M.J.P., S.H.R., G.S.H.Y., J.J.R., S.OR., L.K.H.), Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrookes Hospital, University of Cambridge, Cambridge CB2 2QQ, United Kingdom
Address all correspondence and requests for reprints to: Lora K. Heisler, Ph.D., Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom. E-mail: lkh30{at}cam.ac.uk.
The neurotransmitter serotonin (5-hydroxytryptamine) is a well-established modulator of energy balance. Both pharmacological and genetic evidence implicate the serotonin 2C receptor (5-HT2CR) as a critical receptor mediator of serotonins effects on ingestive behavior. Here we characterized the effect of the novel and selective 5-HT2CR agonist BVT.X on energy balance in obese and lean mice and report that BVT.X significantly reduces acute food intake without altering locomotor activity or oxygen consumption. In an effort to elucidate the mechanism of this effect, we examined the chemical phenotype of 5-HT2CR-expressing neurons in a critical brain region affecting feeding behavior, the arcuate nucleus of the hypothalamus. We show that 5-HT2CRs are coexpressed with neurons containing proopiomelanocortin, known to potently affect appetite, in the arcuate nucleus of the hypothalamus of the mouse. We then demonstrate that prolonged infusion with BVT.X in obese mice significantly increases Pomc mRNA and reduces body weight, percent body fat, and initial food intake. To evaluate the functional importance of melanocortin circuitry in the effect of BVT.X on ingestive behavior, we assessed mice with disrupted melanocortin pathways. We report that mice lacking the melanocortin 4 receptor are not responsive to BVT.X-induced hypophagia, demonstrating that melanocortins acting on melanocortin 4 receptor are a requisite downstream pathway for 5-HT2CR agonists to exert effects on food intake. The data presented here not only indicate that the novel 5-HT2CR agonist BVT.X warrants further investigation as a treatment for obesity but also elucidate specific neuronal pathways potently affecting energy balance through which 5-HT2CR agonists regulate ingestive behavior.
This article has been cited by other articles:
![]() |
C. M. Doe, D. Relkovic, A. S. Garfield, J. W. Dalley, D. E.H. Theobald, T. Humby, L. S. Wilkinson, and A. R. Isles Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour Hum. Mol. Genet., June 15, 2009; 18(12): 2140 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Asarian Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R51 - R56. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Garfield and L. K. Heisler Pharmacological targeting of the serotonergic system for the treatment of obesity J. Physiol., January 1, 2009; 587(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawahara, A. Grimberg, S. Teegarden, C. Mombereau, S. Liu, T. L. Bale, J. A. Blendy, and K. Nishikura Dysregulated Editing of Serotonin 2C Receptor mRNAs Results in Energy Dissipation and Loss of Fat Mass J. Neurosci., November 26, 2008; 28(48): 12834 - 12844. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Miller and A. V. Azzara An Old Dog Learns a New Trick: Regulation of Peripheral Glucose Homeostasis by the Serotonin (5-HT)2C Receptor Mol. Interv., April 1, 2008; 8(2): 73 - 77. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |